Skip to main content
Clinical Trials/NCT04979000
NCT04979000CompletedNot Applicable

The Role of High-risk HPV in Sinonasal Carcinomas: a Retrospective Tissue Analysis of the Increasing Frequency and Case-control Study to Evaluate the Association of HPV Serology and Behavioral Risk Factors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1 site in 1 country49 target enrollmentStarted: August 3, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
49
Locations
1
Primary Endpoint
HPV Status

Study Overview

Brief Summary

This is a case-control study designed to evaluate the role of anatomic site, gender and race in human papillomavirus-associated head and neck squamous cell cancers (HNSCC). We will explore the role of HPV, tobacco, alcohol and drug use, in HNSCC by tumor site with particular emphasis on the sinonasal cavity as well as differences in risk factors for HPV-positive HNSCC by gender and race.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients must be 18 years of age or older with a confirmed or suspected diagnosis of sinonasal cancer
  • Patients must have either a routine diagnostic biopsy of primary tumor or surgical resection planned as part of routine care (to allow for the collection of tumor sample for the study) or grant access to archival material, from a previously performed biopsy.
  • Willing to provide 20 mL blood sample
  • Ability to understand and the willingness to sign a written informed consent document
  • Controls:
  • Must be 18 years of age or older within the categories of age, gender, and race needed to match cases
  • Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria

  • Presence of medical or psychiatric condition affecting ability to give voluntary, informed consent
  • Participants who do not speak English and do not agree to use of a telephone or video interpreter will be excluded. However, if there is a hearing, literally or minor fluency issue and the participant requests assistance from a family member or the study coordinator, this individual may still enroll and receive this assistance to ensure they fully hear and understand everything being asked
  • Controls:
  • Presence of medical or psychiatric condition affecting ability to give voluntary, informed consent
  • Participants who do not speak English and do not agree to use of a telephone or video interpreter will be excluded. However, if there is a hearing, literacy or minor fluency issue and the participant requests assistance from a family member or the study coordinator, this individual may still enroll and receive this assistance to ensure they fully hear and understand everything being asked
  • No prior diagnosis of head and neck cancer, except basal cell cancer
  • No previous radiation therapy of the head and neck

Outcomes

Primary Outcomes

HPV Status

Time Frame: Collected at time of surgery or previously conducted biopsy

High risk HPV present or absent in tumor

Secondary Outcomes

  • Race/Ethnicity Differences(completion of the study, approximately 2 years)
  • Gender Differences(completion of the study, approximately 2 years)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

HPV in Sinonasal Ca: Retrospective... | Clinical Trial